Similar articles for PMID: 10588099

1

Cite

Share

Unusual cervical spinal cord toxicity associated with intra-arterial carboplatin, intra-arterial or intravenous etoposide phosphate, and intravenous cyclophosphamide in conjunction with osmotic blood brain-barrier disruption in the vertebral artery.

Fortin D, McAllister LD, Nesbit G, Doolittle ND, Miner M, Hanson EJ, Neuwelt EA. Fortin D, et al. AJNR Am J Neuroradiol. 1999 Nov-Dec;20(10):1794-802. AJNR Am J Neuroradiol. 1999. PMID: 10588099 Free PMC article.

Cite

Share

2

Cite

Share

The potential for complete and durable response in nonglial primary brain tumors in children and young adults with enhanced chemotherapy delivery.

Dahlborg SA, Petrillo A, Crossen JR, Roman-Goldstein S, Doolittle ND, Fuller KH, Neuwelt EA. Dahlborg SA, et al. Cancer J Sci Am. 1998 Mar-Apr;4(2):110-24. Cancer J Sci Am. 1998. PMID: 9532413

Cite

Share

3

Cite

Share

Brain metastases from fallopian tube carcinoma responsive to intra-arterial carboplatin and intravenous etoposide: a case report.

Newton HB, Stevens C, Santi M. Newton HB, et al. J Neurooncol. 2001 Dec;55(3):179-84. doi: 10.1023/a:1013811612546. J Neurooncol. 2001. PMID: 11859973

Cite

Share

4

Cite

Share

Intra-arterial chemotherapy with osmotic blood-brain barrier disruption for aggressive oligodendroglial tumors: results of a phase I study.

Guillaume DJ, Doolittle ND, Gahramanov S, Hedrick NA, Delashaw JB, Neuwelt EA. Guillaume DJ, et al. Neurosurgery. 2010 Jan;66(1):48-58; discussion 58. doi: 10.1227/01.. Neurosurgery. 2010. PMID: 20023537 Free PMC article. Clinical Trial.

Cite

Share

5

Cite

Share

Intra-arterial carboplatin and intravenous etoposide for the treatment of recurrent and progressive non-GBM gliomas.

Newton HB, Slivka MA, Stevens CL, Bourekas EC, Christoforidis GA, Baujan MA, Chakeres DW. Newton HB, et al. J Neurooncol. 2002 Jan;56(1):79-86. doi: 10.1023/a:1014498225405. J Neurooncol. 2002. PMID: 11949830 Clinical Trial.

Cite

Share

6

Cite

Share

Enhanced chemotherapy delivery by intraarterial infusion and blood-brain barrier disruption in the treatment of cerebral metastasis.

Fortin D, Gendron C, Boudrias M, Garant MP. Fortin D, et al. Cancer. 2007 Feb 15;109(4):751-60. doi: 10.1002/cncr.22450. Cancer. 2007. PMID: 17211866 Free article. Clinical Trial.

Cite

Share

7

Cite

Share

Intraarterial chemotherapy and osmotic blood-brain barrier disruption for patients with embryonal and germ cell tumors of the central nervous system.

Jahnke K, Kraemer DF, Knight KR, Fortin D, Bell S, Doolittle ND, Muldoon LL, Neuwelt EA. Jahnke K, et al. Cancer. 2008 Feb 1;112(3):581-8. doi: 10.1002/cncr.23221. Cancer. 2008. PMID: 18072268 Free article. Clinical Trial.

Cite

Share

8

Cite

Share

Combined intraarterial carboplatin, intraarterial etoposide phosphate, and IV Cytoxan chemotherapy for progressive optic-hypothalamic gliomas in young children.

Osztie E, Várallyay P, Doolittle ND, Lacy C, Jones G, Nickolson HS, Neuwelt EA. Osztie E, et al. AJNR Am J Neuroradiol. 2001 May;22(5):818-23. AJNR Am J Neuroradiol. 2001. PMID: 11337321 Free PMC article.

Cite

Share

9

Cite

Share

Intra-arterial carboplatin and intravenous etoposide for the treatment of metastatic brain tumors.

Newton HB, Slivka MA, Volpi C, Bourekas EC, Christoforidis GA, Baujan MA, Slone W, Chakeres DW. Newton HB, et al. J Neurooncol. 2003 Jan;61(1):35-44. doi: 10.1023/a:1021218207015. J Neurooncol. 2003. PMID: 12587794

Cite

Share

10

Cite

Share

Toxicity and efficacy of carboplatin and etoposide in conjunction with disruption of the blood-brain tumor barrier in the treatment of intracranial neoplasms.

Williams PC, Henner WD, Roman-Goldstein S, Dahlborg SA, Brummett RE, Tableman M, Dana BW, Neuwelt EA. Williams PC, et al. Neurosurgery. 1995 Jul;37(1):17-27; discussion 27-8. doi: 10.1227/00006123-199507000-00003. Neurosurgery. 1995. PMID: 8587686 Clinical Trial.

Cite

Share